Behance Facebook Instagram Linkedin X Vimeo VKontakte Youtube
Sign in
  • Home
  • Biotech News
  • Conferences
    • Gold Conferences
    • Biotech Conferences
    • Technology Conferences
  • CoronaVirus
    • Precision Vaccinations
  • Internet News
  • Research
  • Reverse Splits
    • Reverse Split News
    • Reverse Split Watch List
    • Reverse Stock Split List
    • Upcoming Reverse Stock Split List
  • More Finance Channels
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Psychedelic Stocks
    • Stand Down – Wall Street Bears
    • Tiki Hut Fund
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
Wednesday, August 12, 2026
  • Sign in / Join
  • Contact Us
  • Featured News
  • Free Weekly Newsletter
Behance Facebook Instagram Linkedin X Vimeo VKontakte Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Internet | Biotech Stock Review
  • Home
  • Biotech News
  • Conferences
    • Gold Conferences
    • Biotech Conferences
    • Technology Conferences
  • CoronaVirus
    • Precision Vaccinations
  • Internet News
  • Research
  • Reverse Splits
    • Reverse Split News
    • Reverse Split Watch List
    • Reverse Stock Split List
    • Upcoming Reverse Stock Split List
  • More Finance Channels
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Psychedelic Stocks
    • Stand Down – Wall Street Bears
    • Tiki Hut Fund
Home Biotech News 2020 Watch List Dyadic (DYAI) Price Target $12.
Dyadic, Biotech Stock Review
  • Biotech News
  • 2020 Watch List
  • All News
  • Client
  • CoronaVirus
  • Research
  • Superbug News - CoronaVirus Watch List

Dyadic (DYAI) Price Target $12.

By
Editor / Curator
-
November 6, 2020
Facebook
X
Pinterest
Linkedin
Email
    • TAGS
    • DYAI
    Facebook
    X
    Pinterest
    Linkedin
    Email
      Previous articleDalrada (DFCO) Removes Shell Company Status.
      Next articleAdding Galaxy Digital (GLXY) $5.19 to Watch List.
      Editor / Curator
      Editor / Curator

      RELATED ARTICLESMORE FROM AUTHOR

      2026 Watch List

      Adding BCM Resources Corporation (B.V) $0.27, Up 42%, to Watch List.

      All News

      New Report on Sekur Private Data (SWISF). Palantir’s Open Secure AI.

      2026 Biotech 12 Pack

      Replimune Hurricane Party!

      All News

      CFO Primer. Tokenize Your Stock?

      2023 Watch List

      Inside the Wild Ride of ATAI (ATAI) $7.22. We’re Up And Out, With a 301% Gain.

      All News

      AI Meets Mining. MineSignal.AI – Public Inputs – Proprietary Outputs.

      Reverse Stock Split, Watch List

      Plan Your Day Wisely

      August 2026
      M T W T F S S
       12
      3456789
      10111213141516
      17181920212223
      24252627282930
      31  
      « Jul    

      AI Powered Biotech Research Tool

      Reverse Stock Split News

      Institutional Gold Research

      Latest article

      Adding BCM Resources Corporation (B.V) $0.27, Up 42%, to Watch List.

      2026 Watch List Editor / Curator - August 6, 2026
      'Elephant Hunter' Dr. Sergei Diakov is Expanding Drill Footprint, to Outline a Potentially Massive Copper-Gold System Beneath the Surface. Led by legendary geologist Dr. Sergei...

      New Report on Sekur Private Data (SWISF). Palantir’s Open Secure AI.

      All News Editor - August 4, 2026
      Palantir CEO Alex Karp discusses open-weight artificial intelligence models, how he believes the technology should be regulated and why the U.S. should avoid Europe’s...

      Replimune (REPL) Jumps 100%.

      Uncategorized Editor / Curator - July 31, 2026
      A Nifty $415 Million Gain (in an hour) for Shareholders. Not out of the woods yet.. Short and to the point: We listened to whole meeting...
      Revelers.IO Finance Channel
      The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
      Contact us: roland@institutionalanalyst.com
      • Model Portfolio
      • Disclaimer
      • Contact us
      • Write For Us
      © Managed by Revelers.IO Media Group Inc.